Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eagle Pharmaceuticals
(NQ:
EGRX
)
2.140
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.140
Bid (Size)
2.270 (191)
Ask (Size)
2.330 (37)
Prev. Close
2.140
Today's Range
2.140 - 2.140
52wk Range
2.140 - 6.810
Shares Outstanding
12,698,566
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 02, 2024
Via
Benzinga
Crude Oil Edges Higher; ConAgra Posts Downbeat Earnings
October 02, 2024
Via
Benzinga
Exposures
Fossil Fuels
Performance
YTD
-62.19%
-62.19%
1 Month
N/A
N/A
3 Month
-49.65%
-49.65%
6 Month
-42.32%
-42.32%
1 Year
-64.39%
-64.39%
More News
Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 02, 2024
Via
Benzinga
Dow Gains 100 Points; Joby Aviation Shares Spike Higher
October 02, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Edge Lower; Private Employment Beats Expectations
October 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 22, 2024
Via
Benzinga
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
February 08, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
EAGLE PHARMACEUTICALS 48 HOUR DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
February 08, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX
February 06, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX
February 06, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eagle Pharmaceuticals, Golden Heaven, Inspire Medical, and Driven and Encourages Investors to Contact the Firm
February 04, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action – EGRX
February 04, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX
February 02, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX
February 02, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A LEADING LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action – EGRX
February 01, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
EAGLE PHARMACEUTICALS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
February 01, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Eagle Pharmaceuticals, Golden Heaven, and Inspire Medical and Encourages Investors to Contact the Firm
January 31, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX
January 29, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX
January 29, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A TOP RANKED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX
January 28, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A TOP RANKED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important February 9 Deadline in Securities Class Action - EGRX
January 28, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Eagle Pharmaceuticals, Golden Heaven, and Inspire Medical and Encourages Investors to Contact the Firm
January 27, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
January 24, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fisker, Microvast, Eagle Pharmaceuticals, and Golden Heaven and Encourages Investors to Contact the Firm
January 23, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX
January 23, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.